A Water-free 0.1% Cyclosporine A Solution for Treatment of Dry Eye Disease: Results of the Randomized Phase 2B/3 ESSENCE Study

To assess the efficacy, safety, and tolerability of a topical water-free cyclosporine A formulation (CyclASol 0.1% ophthalmic solution) in comparison with vehicle for the treatment of dry eye disease (DED). METHODS: Three hundred twenty-eight patients were enrolled in this prospective, 12-week, mult...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheppard, John D., Wirta, David L., McLaurin, Eugene, Boehmer, Blair E., Ciolino, Joseph B., Meides, Alice S., Schlüter, Thomas, Ousler, George W., Usner, Dale, Krösser, Sonja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cornea 2021
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423142/
https://www.ncbi.nlm.nih.gov/pubmed/34481407
http://dx.doi.org/10.1097/ICO.0000000000002633

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423142/
https://www.ncbi.nlm.nih.gov/pubmed/34481407
http://dx.doi.org/10.1097/ICO.0000000000002633

Ejemplares similares